Johnson Controls is introducing the AtmosAir™ solution to the Australian market in response to the urgent need for a product that can help reduce the spread of viruses such as COVID-19 through indoor air systems, including commercial air conditioning. The system also restores oxygen ion levels and treats germs before they infect people by continuously disinfecting the air.  The bipolar ions intercept infected particles causing them to agglomerate and fall out of the air, actively reducing microorganisms that collect on surfaces (a common source of infection) including bacteria, fungi, mold, spores and airborne viruses such as coronavirus.

North Ryde affordable housing residents are participating in art classes with resident Dorina Petre. The art works will be submitt

Congenital heart disease (CHD) is the leading cause of death and hospitalisation in infants, affecting one in 100 births. The potential for a genetic link to the condition is now being explored in a new Australian Genomics study supported by HeartKids.So far advanced genetic testing could potentially identify the cause of conditions in up to 50% of families, helping to improve diagnosis, provide better treatment and management outcomes as well as early diagnosis of CHD. 200 families affected by CHD are urged to participate in the study to help researchers.Visit Heartkids for more information!